This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Aug;16(1):1-6.

doi: 10.1007/BF00644958.

Lorcainide infusion in the treatment of ventricular premature beats (VPB)

U Klotz, P M Müller-Seydlitz, P Heimburg

PMID: 499295
DOI: 10.1007/BF00644958

Lorcainide infusion in the treatment of ventricular premature beats (VPB)

U Klotz et al. Eur J Clin Pharmacol. 1979 Aug.

. 1979 Aug;16(1):1-6.

doi: 10.1007/BF00644958.

Authors

U Klotz, P M Müller-Seydlitz, P Heimburg

PMID: 499295
DOI: 10.1007/BF00644958

No abstract available

PubMed Disclaimer

Similar articles

Lorcainide. II. Plasma concentration-effect relationship.
Meinertz T, Kasper W, Kersting F, Just H, Bechtold H, Jähnchen E. Meinertz T, et al. Clin Pharmacol Ther. 1979 Aug;26(2):196-204. doi: 10.1002/cpt1979262196. Clin Pharmacol Ther. 1979. PMID: 455888 No abstract available.
Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agent.
Cocco G, Strozzi C. Cocco G, et al. Eur J Clin Pharmacol. 1978 Nov 16;14(2):105-9. doi: 10.1007/BF00607440. Eur J Clin Pharmacol. 1978. PMID: 363430 Clinical Trial.
Lorcainide. I. Saturable presystemic elimination.
Jähnchen E, Bechtold H, Kasper W, Kersting F, Just H, Heykants J, Meinertz T. Jähnchen E, et al. Clin Pharmacol Ther. 1979 Aug;26(2):187-95. doi: 10.1002/cpt1979262187. Clin Pharmacol Ther. 1979. PMID: 455887 No abstract available.
Flecainide: a new agent for the treatment of ventricular arrhythmias.
Grubb BP, Tilley-Gray B. Grubb BP, et al. Am J Med Sci. 1986 Sep;292(3):160-3. doi: 10.1097/00000441-198609000-00008. Am J Med Sci. 1986. PMID: 3529958 Review.
The treatment of ventricular rhythm disturbances.
Somberg JC, Miura D, Keefe DL. Somberg JC, et al. Am Heart J. 1986 Jun;111(6):1162-76. doi: 10.1016/0002-8703(86)90021-9. Am Heart J. 1986. PMID: 2424297 Review. No abstract available.

See all similar articles

Cited by

New antiarrhythmic drugs: their place in therapy.
Keefe DL, Kates RE, Harrison DC. Keefe DL, et al. Drugs. 1981 Nov;22(5):363-400. doi: 10.2165/00003495-198122050-00002. Drugs. 1981. PMID: 6800757 Review. No abstract available.
Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Eiriksson Ce, Brogden RN. Eiriksson Ce, et al. Drugs. 1984 Apr;27(4):279-300. doi: 10.2165/00003495-198427040-00001. Drugs. 1984. PMID: 6373222 Review.
Adverse effects of antiarrhythmic drugs.
Schwartz JB, Keefe D, Harrison DC. Schwartz JB, et al. Drugs. 1981 Jan;21(1):23-45. doi: 10.2165/00003495-198121010-00002. Drugs. 1981. PMID: 7009136 Review. No abstract available.

References

1. Clin Pharmacol Ther. 1976 Apr;19(4):396-402 - PubMed
1. N Engl J Med. 1967 Dec 7;277(23):1215-9 - PubMed
1. Circulation. 1973 May;47(5):959-66 - PubMed
1. Circulation. 1971 Feb;43(2):205-11 - PubMed
1. Eur J Clin Pharmacol. 1978 Nov 16;14(2):105-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer